Company Data
Praxis Precision Medicines Inc.
Ticker
PRAX
Current Price
$74.49 -6.35%
Market Cap
$1.4B
Price Target
Refer to Report
Volume
495.5K
52wk Range
$33.01 - $91.83
Overview
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm’s pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson’s Disease; PRAX-562, and PRAX-222, among others.